AMO Pharma reveals data from myotonic dystrophy study pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with.
Current investors in AMO Pharma increase funding as Company passes two-thirds enrollment milestone in REACH-CDM pivotal clinical trial LONDON, May 10, 2022 /PRNewswire/ AMO Pharma Limited
LONDON, Oct. 14, 2021 /PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no
/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with.